Literature DB >> 30522925

Venous perfusion assist system has no additional effect compared to simple elevation on post-operative edema in patients with distal radial fracture treated with volar locking plate fixation: A randomized controlled trial.

Hiroshi Yamazaki1, Masanori Hayashi2, Shunsuke Miyaoka3, Shun Hashimoto3, You Kitamura3, Fumihiro Isobe3, Hiroyuki Kato2.   

Abstract

BACKGROUND: While limb elevation and other methods for reducing hand edema are commonly used in clinical practice, alternative methods, such as compression and venous perfusion assist system (VPAS), have emerged. This study compared the efficacy of VPAS to limb elevation in decreasing hand edema after surgery for distal radial fracture (DRF) treated by a volar locking plate (VLP).
METHODS: A randomized controlled trial was conducted in 102 patients to compare VPAS and elevation methods for edema reduction following VLP fixation for DRF. Changes in edema were measured using the tape measure method along with other parameters on the next day and at one, three, six, and 12 weeks postoperatively.
RESULTS: There were no significant differences in edema reduction or other factors between the VPAS and elevation groups at any measurement point.
CONCLUSIONS: VPAS appears to confer no measurable advantage over management with elevation for edema reduction after VLP fixation of DRF. TRIALS REGISTRY: This study was registered at the University Hospital Medical Information Network Clinical Trials Registry (UMIN000015640).
Copyright © 2018 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30522925     DOI: 10.1016/j.jos.2018.11.009

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  1 in total

1.  Limb edema in critically ill patients: Comparing intermittent compression and elevation.

Authors:  Mehdi Ahmadinejad; Farideh Razban; Yunes Jahani; Faezeh Heravi
Journal:  Int Wound J       Date:  2022-01-06       Impact factor: 3.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.